PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON

膳食葡萄源低剂量白藜芦醇对结肠的 I 期生物标志物研究

• 批准号: 7951074
• 负责人: RANDALL F HOLCOMBE
• 金额: $ 6.51万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951074
• 关键词: Biological Markers; Clinical Research; Colon Carcinoma; Computer Retrieval of Information on Scientific Projects Database; Dose; Funding; Genus Cola; Grant; Grapes; Institution; Phase; Research; Research Personnel; Resources; Resveratrol; Source; United States National Institutes of Health; cancer prevention

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Phase I biomarker study of dietary grape-derived low dose resveratrol for colon cancer prevention

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 第一阶段的生物标志物研究饮食葡萄衍生的低剂量白藜芦醇预防结肠癌